Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

Uniform and extremely small-sized iron oxide nanoparticles (ESIONs) of < 4 nm were synthesized via the thermal decomposition of iron-oleate complex in the presence of oleyl alcohol. Oleyl alcohol lowered the reaction temperature by reducing iron-oleate complex, resulting in the production of small-sized nanoparticles. XRD pattern of 3 nm-sized nanoparticles revealed maghemite crystal structure. These nanoparticles exhibited very low magnetization derived from the spin-canting effect. The hydrophobic nanoparticles can be easily transformed to water-dispersible and biocompatible nanoparticles by capping with the poly(ethylene glycol)-derivatized phosphine oxide (PO-PEG) ligands. Toxic response was not observed with Fe concentration up to 100 μg/mL in MTT cell proliferation assay of POPEG-capped 3 nm-sized iron oxide nanoparticles. The 3 nm-sized nanoparticles exhibited a high r(1) relaxivity of 4.78 mM(-1) s(-1) and low r(2)/r(1) ratio of 6.12, demonstrating that ESIONs can be efficient T(1) contrast agents. The high r(1) relaxivities of ESIONs can be attributed to the large number of surface Fe(3+) ions with 5 unpaired valence electrons. In the in vivo T(1)-weighted magnetic resonance imaging (MRI), ESIONs showed longer circulation time than the clinically used gadolinium complex-based contrast agent, enabling high-resolution imaging. High-resolution blood pool MR imaging using ESIONs enabled clear observation of various blood vessels with sizes down to 0.2 mm. These results demonstrate the potential of ESIONs as T(1) MRI contrast agents in clinical settings.

[1]  Mingyuan Gao,et al.  Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging , 2011, Nanotechnology.

[2]  Taeghwan Hyeon,et al.  Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells , 2011, Journal of the American Chemical Society.

[3]  Taeghwan Hyeon,et al.  Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets , 2011, Proceedings of the National Academy of Sciences.

[4]  S. Duckett,et al.  Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating. , 2010, Chemical communications.

[5]  Zhichuan J. Xu,et al.  One-pot synthesis of Fe3O4 nanoprisms with controlled electrochemical properties. , 2010, Chemical communications.

[6]  Xiaoxia Du,et al.  Silica‐Coated Manganese Oxide Nanoparticles as a Platform for Targeted Magnetic Resonance and Fluorescence Imaging of Cancer Cells , 2010 .

[7]  Dingsheng Wang,et al.  One-pot protocol for Au-based hybrid magnetic nanostructures via a noble-metal-induced reduction process. , 2010, Journal of the American Chemical Society.

[8]  Frank C J M van Veggel,et al.  Surface modification of upconverting NaYF4 nanoparticles with PEG-phosphate ligands for NIR (800 nm) biolabeling within the biological window. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[9]  Taeghwan Hyeon,et al.  Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent , 2009 .

[10]  R. Cole,et al.  Size-Controlled Synthesis of Quasi-Monodisperse Transition-Metal Ferrite Nanocrystals in Fatty Alcohol Solutions , 2009 .

[11]  Oliver T. Bruns,et al.  A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. , 2009, Nano letters.

[12]  T. Hyeon,et al.  Nanostructured T1 MRI contrast agents , 2009 .

[13]  Taeghwan Hyeon,et al.  Inorganic Nanoparticles for MRI Contrast Agents , 2009 .

[14]  W. Moon,et al.  Various-Shaped Uniform Mn3O4 Nanocrystals Synthesized at Low Temperature in Air Atmosphere , 2009 .

[15]  Timothy J Shaw,et al.  Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. , 2009, Small.

[16]  Taeghwan Hyeon,et al.  Synthesis of uniform ferrimagnetic magnetite nanocubes. , 2009, Journal of the American Chemical Society.

[17]  Young Woon Kim,et al.  Synthesis of uniform hollow oxide nanoparticles through nanoscale acid etching. , 2008, Nano letters.

[18]  Taeghwan Hyeon,et al.  Simple and generalized synthesis of oxide-metal heterostructured nanoparticles and their applications in multimodal biomedical probes. , 2008, Journal of the American Chemical Society.

[19]  A. Jasanoff,et al.  T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations. , 2008, Magnetic resonance imaging.

[20]  Bing Xu,et al.  Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. , 2008, Journal of the American Chemical Society.

[21]  Peter C M van Zijl,et al.  MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles , 2008, Magnetic resonance in medicine.

[22]  Jinwoo Cheon,et al.  Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. , 2008, Angewandte Chemie.

[23]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[24]  Haitao Yang,et al.  Synthesis and magnetic properties of monodisperse magnetite nanocubes , 2008 .

[25]  J. Cheon,et al.  Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. , 2008, Accounts of chemical research.

[26]  Weili Lin,et al.  Mesoporous silica nanospheres as highly efficient MRI contrast agents. , 2008, Journal of the American Chemical Society.

[27]  Taeghwan Hyeon,et al.  Versatile PEG-derivatized phosphine oxide ligands for water-dispersible metal oxide nanocrystals. , 2007, Chemical communications.

[28]  R. Reilly,et al.  What nephrologists need to know about gadolinium , 2007, Nature Clinical Practice Nephrology.

[29]  Stefan Vogt,et al.  DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. , 2007, Journal of the American Chemical Society.

[30]  J. Marco,et al.  Effect of Nature and Particle Size on Properties of Uniform Magnetite and Maghemite Nanoparticles , 2007 .

[31]  T. Hyeon,et al.  Kinetics of monodisperse iron oxide nanocrystal formation by "heating-up" process. , 2007, Journal of the American Chemical Society.

[32]  D. Bilecen,et al.  MR angiography with blood pool contrast agents , 2007, European Radiology.

[33]  Sung Tae Kim,et al.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.

[34]  Weili Lin,et al.  Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. , 2007, Journal of the American Chemical Society.

[35]  Taeghwan Hyeon,et al.  Synthesis of monodisperse spherical nanocrystals. , 2007, Angewandte Chemie.

[36]  Shouheng Sun,et al.  Synthesis and characterization of monodisperse hollow Fe3O4 nanoparticles. , 2007, Angewandte Chemie.

[37]  Weili Lin,et al.  Hybrid silica nanoparticles for multimodal imaging. , 2007, Angewandte Chemie.

[38]  M. Kovalenko,et al.  Fatty acid salts as stabilizers in size- and shape-controlled nanocrystal synthesis: the case of inverse spinel iron oxide. , 2007, Journal of the American Chemical Society.

[39]  Robert N Grass,et al.  Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. , 2007, Environmental science & technology.

[40]  P. Perriat,et al.  Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.

[41]  Anna Roig,et al.  Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[42]  Younan Xia,et al.  Superparamagnetic Colloids: Controlled Synthesis and Niche Applications , 2007 .

[43]  A. Tanimoto,et al.  Gadolinium-based hybrid nanoparticles as a positive MR contrast agent. , 2006, Journal of the American Chemical Society.

[44]  Wolfgang Gawalek,et al.  Nanocrystalline iron oxide and Ba ferrite particles in the superparamagnetism-ferromagnetism transition range with ferrofluid applications , 2006 .

[45]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[46]  Jin-Sil Choi,et al.  In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.

[47]  Paul Mulvaney,et al.  Nucleation and growth of CdSe nanocrystals in a binary ligand system. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[48]  W. Ou,et al.  Photoactivation of quantum dot fluorescence following endocytosis. , 2005, Nano letters.

[49]  T. Hyeon,et al.  One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. , 2005, Angewandte Chemie.

[50]  A. Roch,et al.  Superparamagnetic colloid suspensions: Water magnetic relaxation and clustering , 2005 .

[51]  Jinwoo Cheon,et al.  Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[52]  R. Willette,et al.  Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling , 2005, Journal of magnetic resonance imaging : JMRI.

[53]  Taeghwan Hyeon,et al.  Large‐Scale Synthesis of Uniform and Crystalline Magnetite Nanoparticles Using Reverse Micelles as Nanoreactors under Reflux Conditions , 2005 .

[54]  Taeghwan Hyeon,et al.  Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.

[55]  W. Heindel,et al.  First‐pass and equilibrium‐MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study , 2004, NMR in biomedicine.

[56]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[57]  Atle Bjørnerud,et al.  The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.

[58]  M. Yin,et al.  Magnetic, electronic, and structural characterization of nonstoichiometric iron oxides at the nanoscale. , 2004, Journal of the American Chemical Society.

[59]  William W. Yu,et al.  Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. , 2004, Chemical communications.

[60]  Xiaogang Peng,et al.  Size- and Shape-Controlled Magnetic (Cr, Mn, Fe, Co, Ni) Oxide Nanocrystals via a Simple and General Approach , 2004 .

[61]  Hong Yang,et al.  Effects of surfactants and synthetic conditions on the sizes and self-assembly of monodisperse iron oxide nanoparticles , 2004 .

[62]  J. Cheon,et al.  Shape evolution of single-crystalline iron oxide nanocrystals. , 2004, Journal of the American Chemical Society.

[63]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[64]  María del Puerto Morales,et al.  Static and dynamic magnetic properties of spherical magnetite nanoparticles , 2003 .

[65]  Taeghwan Hyeon,et al.  Chemical synthesis of magnetic nanoparticles. , 2003, Chemical communications.

[66]  A. Roch,et al.  Characterization of polydisperse superparamagnetic particles by nuclear magnetic relaxation dispersion (NMRD) profiles , 2002 .

[67]  Eric E. Fullerton,et al.  Magnetic recording: advancing into the future , 2002 .

[68]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[69]  Hao Zeng,et al.  Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.

[70]  C. Bremer,et al.  Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. , 2002, Radiology.

[71]  R. Brooks,et al.  T2‐shortening by strongly magnetized spheres: A chemical exchange model † , 2002, Magnetic resonance in medicine.

[72]  Taeghwan Hyeon,et al.  Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. , 2001, Journal of the American Chemical Society.

[73]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[74]  J. Idee,et al.  Reversibility of experimental acute renal failure in rats: Assessment with USPIO‐enhanced MR imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[75]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[76]  A. P. Alivisatos,et al.  A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides , 1999 .

[77]  A. Ragnarsson,et al.  Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study. , 1999, Radiology.

[78]  Robert N. Muller,et al.  Theory of proton relaxation induced by superparamagnetic particles , 1999 .

[79]  T. Teranishi,et al.  Size Control of Palladium Nanoparticles and Their Crystal Structures , 1998 .

[80]  B. Tombach,et al.  Hepatic MRI with SPIO: detection and characterization of focal liver lesions , 1998, European Radiology.

[81]  Mark A. Brown,et al.  MRI: Basic Principles and Applications , 1995 .

[82]  P. Hendriksen,et al.  On spin‐canting in maghemite particles , 1994 .

[83]  T J Brady,et al.  Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. , 1992, Radiology.

[84]  R. Perdrisot,et al.  Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. , 1991, Magnetic resonance imaging.

[85]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[86]  Roy W. Chantrell,et al.  Measurements of particle size distribution parameters in ferrofluids , 1978 .

[87]  J. Coey.  Noncollinear Spin Arrangement in Ultrafine Ferrimagnetic Crystallites , 1971 .